Ask AI

Redefining HCC Treatment in the Immunotherapy Era: Expert Insights, Multimodal Innovations, and Coordinated Care for Optimal Outcomes Across the Disease Continuum

Enhance your understanding of immunotherapies and targeted agents for the management of hepatocellular carcinoma (HCC). Learn how to effectively implement collaborative-care approaches and evolving guideline recommendations to improve patient care through a certified on-demand webcast, expert-authored ClinicalThought commentary, podcast, and downloadable slides.

Share

Program Content

Events

  • Live Event Redefining HCC Treatment
    Redefining HCC Treatment in the Immunotherapy Era: Expert Insights, Multimodal Innovations, and Coordinated Care for Optimal Outcomes Across the Disease Continuum
    Congratulations: You achieved a completion on 04/09/2022

    You can enroll in the following live event(s) on this topic.

Activities

Advanced HCC
Immunotherapy in Advanced/Metastatic HCC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 28, 2025

Expires: November 27, 2025

ND MM
Management of Newly Diagnosed Multiple Myeloma: Next Steps for Optimal Treatment
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 28, 2025

Expires: November 27, 2025

Early Stage HCC
Data for Immune Checkpoint Inhibitor–Based Therapies in High-Risk Early-Stage HCC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 28, 2025

Expires: November 27, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from Eisai and Merck Sharp & Dohme LLC.

Eisai

Merck Sharp & Dohme, LLC